Skip to main content
Equibles

MORGAN STANLEY

Position in GRI — GRI Bio, Inc.

CIK 895421 NEW YORK, NY
Back to GRI Full portfolio

Position in GRI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$15,464
+$15,464 QoQ
Shares Held
8,737
+9607.8% QoQ
Ownership
0.400%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 11 holders
Holding Since
Sep 2021
6 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GRI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,661,229 across 524 Biotechnology names. GRI ranks #410 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in GRI

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-06-30 $15,464 8,737